Cabometyx Cabozantinib — Highmark
6 indications indexed for this drug.
- Advanced Renal Cell Carcinoma RccView coverage criteria
- Differentiated Thyroid CancerView coverage criteria
- Extra Pancreatic Neuroendocrine Tumors EpnetView coverage criteria
- Hepatocellular CarcinomaView coverage criteria
- Pancreatic Neuroendocrine Tumors PnetView coverage criteria
- Quantity Limit ExceptionView coverage criteria